Open access · CC-BY
via OpenAlex
NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice
Krish Chandrasekaran, Neda Najimi, Avinash Rao Sagi, Sushuma Yarlagadda, Mohammad Salimian, Muhammed Ikbal Arvas, Ahmad F. Hedayat, Yanni Kevas, Anand Kadakia, Tibor Kristián, James William Russell
International Journal of Molecular Sciences · 2024 · ▲ 7 citations
Abstract
Abnormal NAD+ signaling has been implicated in axonal degeneration in diabetic peripheral neuropathy (DPN). We hypothesized that supplementing NAD+ precursors could alleviate DPN symptoms through increasing the NAD+ levels and activating the sirtuin-1 (SIRT1) protein. To test this, we exposed cultured Dorsal Root Ganglion neurons (DRGs) to Nicotinamide Riboside (NR) or Nicotinamide Mononucleotide (NMN), which increased the levels of NAD+, the SIRT1 protein, and the deacetylation activity that is associated with increased neurite growth. A SIRT1 inhibitor blocked the neurite growth induced via NR or NMN. We then induced neuropathy in C57BL6 mice with streptozotocin (STZ) or a high fat diet (HFD) and administered NR or NMN for two months. Both the STZ and HFD mice developed neuropathy, which was reversed through the NR or NMN administration: sensory function improved, nerve conduction velocities normalized, and intraepidermal nerve fibers were restored. The NAD+ levels and SIRT1 activity were reduced in the DRGs from diabetic mice but were preserved with the NR or NMN treatment. We also tested the effect of NR or NMN administration in mice that overexpress the SIRT1 protein in neurons (nSIRT1 OE) and found no additional benefit from the addition of the drug. These findings suggest that supplementing with NAD+ precursors or activating SIRT1 may be a promising treatment for DPN.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3390/ijms25021102
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Chandrasekaran, K., Najimi, N., Sagi, A.R., Yarlagadda, S., Salimian, M., Arvas, M.I., Hedayat, A.F., Kevas, Y., Kadakia, A., Kristián, T., & Russell, J.W. (2024). NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice. <em>International Journal of Molecular Sciences</em>. https://doi.org/10.3390/ijms25021102
Vancouver
Chandrasekaran K, Najimi N, Sagi AR, Yarlagadda S, Salimian M, Arvas MI, et al. NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25021102.
BibTeX
@article{krish2024NADPre,
title = {NAD+ Precursors Reverse Experimental Diabetic Neuropathy in Mice},
author = {Krish Chandrasekaran and Neda Najimi and Avinash Rao Sagi and Sushuma Yarlagadda and Mohammad Salimian and Muhammed Ikbal Arvas and Ahmad F. Hedayat and Yanni Kevas and Anand Kadakia and Tibor Kristián and James William Russell},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25021102},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
International Journal of Molecular Sciences 2022
Open access · CC-BY
NAD+ Precursors Repair Mitochondrial Function in Diabetes and Prevent Experimental Diabetic Neuropathy
Nature Reviews Disease Primers 2019
Open access · OA
Diabetic neuropathy
Rejuvenation Research 2017
Citation only
The NAD+/PARP1/SIRT1 Axis in Aging
International Journal of Molecular Sciences 2020
Open access · CC-BY
Nicotinamide Mononucleotide Administration Prevents Experimental Diabetes-Induced Cognitive Impairment and Loss of Hippocampal Neurons
Molecular Biology of the Cell 2013
Preprint · CC-BY
Effects of hyperglycemia and aging on nuclear sirtuins and DNA damage of mouse hepatocytes
Nutrients 2023
Open access · CC-BY